Antibody drop in newborns congenitally infected by Trypanosoma cruzi treated with benznidazole

Tropical Medicine and International Health

Volumn 15, Issue 1, 2010, Pages 87-93

  Chippaux, Jean Philippe ^a,b   Clavijo, Alejandra N Salas ^a   Santalla, Jose A ^b   Postigo, Jorge R ^a   Schneider, Dominique ^c   Brutus, Laurent ^c  

^a Institut de recherche pour le developpement Bolivia   (Bolivia)

^b Instituto Nacional de Laboratorios de Salud Bolivia   (Bolivia)

^c INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

Author keywords

Benznidazole; Chagas disease; Congenital infection; Immune response; Treatment

Indexed keywords

BENZNIDAZOLE;

ANTIBODY; DISEASE TREATMENT; HEALTH CARE; IMMUNE RESPONSE; IMMUNOASSAY; INFECTIOUS DISEASE; TEMPORAL PERIOD;

ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CHAGAS DISEASE; CHROMATOGRAPHY; CLINICAL TRIAL; CONGENITAL INFECTION; CONTROLLED STUDY; CONVALESCENCE; DOSAGE SCHEDULE COMPARISON; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NEWBORN; RELIABILITY; SEROLOGY; TREATMENT OUTCOME; TRYPANOSOMA CRUZI;

TRYPANOSOMA CRUZI;

EID: 72349097864     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2009.02431.x     Document Type: Article

References (31)

1. Altcheh J, Corral R, Biancardi MA Freilij H (2003) Anticuerpos anti-F2/3 como marcador de curacion en niños con infeccion congenital por Trypanosoma cruzi. Medicina 63, 37 40.
2. Andrade de SG, Freitas LAR, Peyrol S, Pimentel AR Sadigursky M (1988) Trypanosoma cruzi antigens detected by immunoelectron microscopy in the spleen of mice serologically positive but parasitologically cured by chemotherapy. Revista da Sociedade Brasileira de Medicina Tropical 21, 41 42.
3. Anonymous (2003) Congenital infection with Trypanosoma cruzi: from mechanisms of transmission to strategies for diagnosis and control. Revista da Sociedade Brasileira de Medicina Tropical 36, 767 771.
4. Blanco SB, Segura EL, Cura EN et al. (2000) Congenital transmission of Trypanosoma cruzi: an operational outline for detecting and treating infected infants in north-western Argentina. Tropical Medicine & International Health 5, 293 301.
5. Brenière SF, Bailly M, Carrasco R Carlier Y (1983) Transmission transplacentaire des anticorps anti-Trypanosoma cruzi. Cahiers ORSTOM, Série Entomologie médicale et Parasitologie 21, 139 140.
6. Carrasco R, Miguez H, Camacho C et al. (1990) Prevalence of Trypanosoma cruzi infection in blood banks of seven departments of Bolivia. Memorias do Instituto Oswaldo Cruz 85, 69 73.
7. Cerisola JA, Alvarez M De Rissio AM (1970) Imunodiagnóstico da doença de Chagas. Evolução sorológica de pacientes com doença de Chagas. Revista do Instituto de Medicina Tropical de São Paulo 12, 403 411.
8. Chippaux JP, Postigo JR, Santalla JA, Schneider D Brutus L (2008) Epidemiological evaluation of Chagas disease in a rural area of southern Bolivia. Transactions of the Royal Society of Tropical Medicine & Hygiene 102, 578 584.
9. ® test in Bolivia. Tropical Medicine & International Health 14, 732 735.
10. Corral RS, Altcheh JM Freilij HL (1998) Presence of IgM antibodies to Trypanosoma cruzi urinary antigen in sera from patients with acute Chagas' disease. International Journal for Parasitology 28, 589 594.
11. Dias JC (2007) Southern Cone Initiative for the elimination of domestic populations of Triatoma infestans and the interruption of transfusion Chagas disease: historical aspects, present situation, and perspectives. Memorias do Instituto Oswaldo Cruz 102 (Suppl. 1 11 18.
12. Diez CN, Manattini S, Zanuttini JC, Bottasso O Marcipar I (2008) The value of molecular studies for the diagnosis of congenital Chagas disease in northeastern Argentina. American Journal of Tropical Medicine & Hygiene 78, 624 627.
13. Freilij H Altcheh J (1995) Congenital Chagas' disease: diagnostic and clinical aspects. Clinical Infectious Diseases 21, 551 555.
14. Freilij H, Muller L Gonzalez Cappa SM (1983) Direct micromethod for diagnosis of acute and congenital Chagas' disease. Journal of Clinical Microbiology 18, 327 330.
15. Gazzinelli RT, Galvao LMC, Cardoso JR et al. (1988) Anti-Trypanosoma cruzi and anti-laminin antibodies in chagasic patients after specific treatment. Journal of Clinical Microbiology 26, 1795 1800.
16. Gazzinelli RT, Galvao LM, Krautz G et al. (1993) Use of Trypanosoma cruzi purified glycoprotein (GP57/51) or trypomastigote-shed antigens to assess cure for human Chagas' disease. American Journal of Tropical Medicine & Hygiene 49, 625 635.
17. Guevara AG, Taibi A, Alava J, Guderian RH Ouaissi A (1995) Use of a recombinant Trypanosoma cruzi protein antigen to monitor cure of Chagas disease. Transactions of the Royal Society of Tropical Medicine & Hygiene 89, 447 448.
18. Guillen G, Diaz R, Jemio A, Cassab JA, Pinto CT Schofield CJ (1997) Chagas disease vector control in Tupiza, southern Bolivia. Memorias do Instituto Oswaldo Cruz 92, 1 8.
19. Lorca M, Veloso C, Munoz P, Bahamonde MI Garcia A (1995) Diagnostic value of detecting specific IgA and IgM with recombinant Trypanosoma cruzi antigens in congenital Chagas' disease. American Journal of Tropical Medicine & Hygiene 52, 512 515.
20. Luquetti A, Ponce C, Ponce E et al. (2003) Chagas' disease diagnosis: a multicentrix evaluation of Chagas Stat-Pak, a rapid immunochromatographic assay with recombinant proteins of Trypanosoma cruzi. Diagnostic Microbiology and Infectious Disease 46, 265 271.
21. Moya P, Moretti E, Paolasso R et al. (1989) Enfermedad de Chagas neonatal. Diagnóstico de laboratorio en el primer año de vida. Medicina 49, 595 599.
22. OPS/OMS (1999) Tratamiento Etiológico de la Enfermedad de Chagas. Conclusiones de una consulta técnica. Washington, DC, OPS/HCP/HCT/140/99. Available at: http://www.paho.org/spanish/ad/dpc/cd/chagas.pdf (accessed 25 March 2009).
23. Park E, Cho M Ki CS (2009) Correct use of repeated-measures analysis of variance. The Korean Journal of Laboratory Medicine 29, 1 9.
24. Pereira-Chioccola VL, Fragata-Filho AA, Levy AM, Rodrigues MM Schenkman S (2003) Enzyme-linked immunoassay using recombinant trans-sialidase of Trypanosoma cruzi can be employed for monitoring of patients with Chagas' disease after drug treatment. Clinical and Diagnostic Laboratory Immunology 10, 826 830.
25. Ponce C, Ponce E, Vinelli E et al. (2005) Validation of a rapid and reliable test for diagnosis of chagas' disease by detection of Trypanosoma cruzi-specific antibodies in blood of donors and patients in Central America. Journal of Clinical Microbiology 43, 5065 5068.
26. Schijman AG, Altcheh J, Burgos JM et al. (2003) Aetiological treatment of congenital Chagas' disease diagnosed and monitored by the polymerase chain reaction. Journal of Antimicrobial Chemotherapy 52, 441 449.
27. Schmuñis GA, Szarfman A, Coarasa L Vainstok C (1978) Immunoglobulin concentration in treated human acute Chagas disease. A follow-up study. American Journal of Tropical Medicine & Hygiene 27, 473 477.
28. Schofield CJ, Jannin J Salvatella R (2006) The future of Chagas disease control. Trends in Parasitology 22, 583 588.
29. Umezawa ES, Bastos SF, Camargo ME et al. (1999) Evaluation of recombinant antigens for serodiagnosis of Chagas' disease in South and Central America. Journal of Clinical Microbiology 37, 1554 1560.
30. Umezawa ES, Bastos SF, Coura JR et al. (2003) An improved serodiagnostic test for Chagas' disease employing a mixture of Trypanosoma cruzi recombinant antigens. Transfusion 43, 91 97.
31. Zaidenberg M Segovia A (1993) La enfermedad de Chagas congenital en la ciudad de Salta, Argentina. Revista do Instituto de Medicina Tropical de São Paulo 35, 35 43.